Anastrozole

• Presentación: 1mg/50tb

• Referencia del proveedor: Anastrobol

Anastrobol by BM is a targeted oral pharmaceutical preparation containing Anastrozole, a potent third-generation non-steroidal selective aromatase inhibitor (AI). It is engineered primarily to block the aromatase enzyme, which is responsible for converting circulating androgens into estrogens, thereby controlling estrogenic side effects in advanced performance settings.

Active Ingredient & Pharmacology

• Anastrozole approx 1mgper tablet): A highly selective aromatase inhibitor capable of reducing systemic estrogen levels by up to 80% to 98%. By neutralizing the aromatization pathway, it prevents estrogen-induced complications such as gynecomastia, excessive water retention, and fluctuating blood pressure.

Comprehensive Administration Protocol

• Dosage Guidelines: Typically administered at a conservative dose of 0.5mgto 1mgtaken every second day (EOD) or twice weekly, depending on individual serum estrogen levels and the aromatizing potency of concurrent compounds.

• Cycle Integration: Utilized concurrently throughout cycles containing aromatizable compounds (such as high-dose testosterones or nandrolones) to maintain a balanced estrogen-to-androgen ratio.

• Post-Cycle and Control: Can also be integrated into targeted post-cycle recovery or clinical protocols under strict supervision to prevent estrogen rebound effects.